AI cameras could spot delirium severity in ICU patients
NCT ID NCT06172491
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a video camera and artificial intelligence can accurately measure delirium severity in ICU patients over 50. Researchers will compare the camera data with standard bedside assessments. The goal is to create a passive digital marker that works automatically, without disturbing patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a reliable, automated way to measure delirium severity in ICU patients, improving care without extra work for nurses.
- What could go wrong
- This is an early observational study, not a treatment trial. The digital marker may not prove accurate or practical in real-world ICU settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2023
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Aging adults admitted to an intensive care unit
- Ages
-
50 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Age \>50; * Estimated length of stay \>24 hours in ICU; and * Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal. Exclusion Criteria: * Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal. * Admitted for acute neuronal injury * Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delirium are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain waves may reveal which children recover from encephalopathy
- Could a quieter, dimmer ICU protect Patients' brains?
- Can a daily supplement shield the brain after delirium?
- Brain surgery delirium: can real-time monitoring protect older patients?
- Could daylight hold the key to preventing delirium?
- Can sensory therapy calm Dementia-Related agitation in hospitals?